Le Lézard
Classified in: Health, Science and technology
Subject: PER

DeepScribe Welcomes Former UnitedHealthcare Executive and Optum CMO as an Advisor


Dr. Miles Snowden, Chief Growth Officer at Navvis, brings his deep physician executive expertise in value-based care and digital health innovation to DeepScribe

SAN FRANCISCO, April 18, 2024 /PRNewswire/ -- DeepScribe, a leader in ambient AI documentation for healthcare, today announced the addition of Dr. Miles Snowden to its advisory board. Dr. Snowden brings over 25 years of healthcare leadership experience that will help guide DeepScribe's strategy as it continues scaling its AI-powered medical documentation platform.

"DeepScribe is at the forefront of using AI to streamline one of the most arduous clinical workflows ? documentation," said Dr. Snowden. "I have enjoyed collaborating with the outstanding DeepScribe team to support their mission of unburdening physicians so they can spend more time focused on patient care."

Dr. Snowden is a healthcare veteran who has held physician executive roles at Delta Air Lines, UnitedHealthcare, Optum, TeamHealth, and Navvis. His experience spans clinical product development, value-based care initiatives, medical informatics, mergers and acquisitions, and business growth strategies.

"Dr. Snowden's extensive background spanning payer, provider, and technology companies will be invaluable as we accelerate adoption of our solutions to reduce clinician burnout and improve patient care through seamless clinical documentation," said Akilesh Bapu, CEO and Co-Founder of DeepScribe. "He is at the forefront of value-based care and how to deliver it at scale from his time at TeamHealth and Navvis."

At DeepScribe, Dr. Snowden will lend his expertise to enhancing the company's AI solutions and go-to-market strategies as it expands partnerships with health systems, physician practices, and payers nationwide.

About DeepScribe
DeepScribe transforms patient conversations into fully customizable clinical documentation with ambient AI. Designed for clinician ease of use and stringent CMIO data requirements, DeepScribe is built on the largest database of natural patient conversations in the world. Leveraging composable AI to allow for customized patient notes, DeepScribe is the only solution flexible enough to meet the needs of every specialty and care setting while maximizing reimbursements. Save time on documentation, modernize enterprise patient data strategy, and unlock the future of digital health. Visit www.deepscribe.ai to learn more.

Media Contact: 
Erin Farrell-Talbot 
917-232-9309
[email protected]

SOURCE DeepScribe


These press releases may also interest you

at 04:21
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...



News published on and distributed by: